Dried blood spots: Concepts, present status, and future perspectives in bioanalysis
- 1 April 2014
- journal article
- review article
- Published by Wiley in Drug Testing and Analysis
- Vol. 6 (5) , 399-414
Abstract
Over the past several years, dried blood spot (DBS) sampling technique has emerged as a pertinent method in both qualitative and quantitative bioanalysis context. In the DBS method, the blood sample is directly soaked on to a paper (with or without treatment). After drying it can be analyzed by modern analytical, immunological, or genomic detection systems. Several advantages of the DBS technique such as low blood volume requirement, transportation and storage without special treatment, better analytes stability, enhanced clinical cooperation in clinical trials, and reduced unforeseeable exposure of analysts to biohazards, make it the most appropriate blood sampling technique. This review illustrates the information available on the DBS method which may serve as a single window for investigators in the field of bioanalysis. Also, it explores the proficiency and appliance of the DBS method in pharmacokinetic (PK), therapeutic drug monitoring (TDM), toxicokinetic (TK), metabolomic, and disease diagnosis. Copyright © 2014 John Wiley & Sons, Ltd.Keywords
This publication has 208 references indexed in Scilit:
- Dried blood spot UHPLC-MS/MS analysis of oseltamivir and oseltamivircarboxylate—a validated assay for the clinicAnalytical and Bioanalytical Chemistry, 2011
- HPLC–MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditionsJournal of Pharmaceutical and Biomedical Analysis, 2010
- Therapeutic drug monitoring of everolimus using the dried blood spot method in combination with liquid chromatography–mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2009
- On-line desorption of dried blood spot: A novel approach for the direct LC/MS analysis of μ-whole blood samplesJournal of Pharmaceutical and Biomedical Analysis, 2009
- Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometryJournal of Pharmaceutical and Biomedical Analysis, 2009
- Rapid assay of topiramate in dried blood spots by a new liquid chromatography-tandem mass spectrometric methodJournal of Pharmaceutical and Biomedical Analysis, 2008
- Simultaneous determination of 17α-hydroxypregnenolone and 17α-hydroxyprogesterone in dried blood spots from low birth weight infants using LC–MS/MSJournal of Pharmaceutical and Biomedical Analysis, 2008
- Determination of rifampicin in human plasma and blood spots by high performance liquid chromatography with UV detection: A potential method for therapeutic drug monitoringJournal of Pharmaceutical and Biomedical Analysis, 2007
- Therapeutic drug monitoring of tacrolimus with the dried blood spot methodJournal of Pharmaceutical and Biomedical Analysis, 2007
- Molecular Confirmation of α1-Antitrypsin Genotypes in Newborn Dried Blood SpecimensBiochemical Medicine and Metabolic Biology, 1993